Skip to content

Analysis of the current status and needs of self-management in patients with drug-resistant tuberculosis at different stages of intensification

Analysis of the current status and needs of self-management in patients with drug-resistant tuberculosis at different stages of intensification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096840
Enrollment
Unknown
Registered
2025-02-07
Start date
2024-02-13
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-resistant tuberculosis

Interventions

Observation group:None

Sponsors

Public Health Clinical Center of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for drug-resistant tuberculosis of the Tuberculosis Branch of the Chinese Medical Association and are DR-TB detected by sputum drug susceptibility test or molecular biology; (2) Age >= 18 years old; (3) Patients who are conscious, have normal speech, and cooperate with the investigation; (4) Informed consent was obtained, and patients voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe liver and kidney diseases; (2) Lack of literacy skills to understand or answer questions; (3) Suffering from psychiatric diseases, such as schizophrenia, dementia, etc.

Design outcomes

Primary

MeasureTime frame
Tuberculosis patient self-management scale;

Secondary

MeasureTime frame
Morisky Medication Adherence Scale;Social Support Rating Scale;Self-efficacy for Managing Chronic Disease 6-item scale;Tuberculosis Knowledge Acquisition Evaluation Form;

Countries

China

Contacts

Public Contactbin Wan

Public Health Clinical Center of Chengdu

673971566@qq.com+86 138 8195 6592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026